Psychemedics(PMD)
Search documents
Psychemedics(PMD) - 2023 Q2 - Quarterly Report
2023-08-14 21:05
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒Quarterly report pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the quarterly period ended June 30, 2023 or ☐Transition report pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 for the transition period from _________ to __________ Commission file number: 1-13738 PSYCHEMEDICS CORPORATION (Exact Name of Registrant as Specified in its Charter) (State or Other Jurisdiction of (I ...
Psychemedics(PMD) - 2023 Q1 - Quarterly Report
2023-05-11 21:15
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly report pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the quarterly period ended March 31, 2023 or ☐ Transition report pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 for the transition period from _________ to __________ Commission file number: 1-13738 PSYCHEMEDICS CORPORATION (Exact Name of Registrant as Specified in its Charter) Delaware 58-1701987 (State or O ...
Psychemedics(PMD) - 2022 Q4 - Annual Report
2023-03-27 14:00
FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 1-13738 PSYCHEMEDICS CORPORATION (Exact Name of Registrant as Specified in Its Charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Delaware 58-1701987 (State or Other Jurisdiction of Incorporation or Organization) 289 Great Roa ...
Psychemedics(PMD) - 2022 Q3 - Quarterly Report
2022-11-10 22:26
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly report pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the quarterly period ended September 30, 2022 or ☐ Transition report pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 for the transition period from _________ to __________ Commission file number: 1-13738 PSYCHEMEDICS CORPORATION (Exact Name of Registrant as Specified in its Charter) Incorporation or Organizati ...
Psychemedics(PMD) - 2022 Q2 - Quarterly Report
2022-08-10 21:16
FORM 10-Q ☒ Quarterly report pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the quarterly period ended June 30, 2022 or ☐ Transition report pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 for the transition period from _________ to __________ Commission file number: 1-13738 PSYCHEMEDICS CORPORATION (Exact Name of Registrant as Specified in its Charter) Delaware 58-1701987 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 (State or Ot ...
Psychemedics(PMD) - 2022 Q1 - Quarterly Report
2022-05-11 21:15
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly report pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the quarterly period ended March 31, 2022 or ☐ Transition report pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 for the transition period from _________ to __________ Commission file number: 1-13738 PSYCHEMEDICS CORPORATION Securities registered pursuant to section 12(b) of the act: | | | registered | | --- | ...
Psychemedics(PMD) - 2021 Q4 - Annual Report
2022-03-30 21:01
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 1-13738 PSYCHEMEDICS CORPORATION (Exact Name of Registrant as Specified in Its Charter) Delaware 58-1701987 (State or Other Jurisdiction of Incorporation or Organization) (I.R.S. Emplo ...
Psychemedics(PMD) - 2021 Q3 - Quarterly Report
2021-11-15 22:01
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly report pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the quarterly period ended September 30, 2021 or ☐ Transition report pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 for the transition period from _________ to __________ Commission file number: 1-13738 PSYCHEMEDICS CORPORATION (Exact Name of Registrant as Specified in its Charter) | Delaware | 58-1701987 | | ...
Psychemedics(PMD) - 2021 Q2 - Quarterly Report
2021-08-12 21:10
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly report pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the quarterly period ended June 30, 2021 or ☐ Transition report pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 for the transition period from _________ to __________ Commission file number: 1-13738 PSYCHEMEDICS CORPORATION (Exact Name of Registrant as Specified in its Charter) 289 Great Road Acton, MA 01720 ( ...
Psychemedics(PMD) - 2021 Q1 - Quarterly Report
2021-05-13 21:19
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly report pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 For the quarterly period ended March 31, 2021 or ☐ Transition report pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 for the transition period from ________ to ________ Commission file number: 1-13738 PSYCHEMEDICS CORPORATION (Exact Name of Registrant as Specified in its Charter) Incorporation or Organization) Del ...